Cristina Saro Gismera, Service of Digestive Diseases, Hospital de Cabueñes, Gijón, Spain
Beatriz Sicilia Aladrén, Service of Digestive Diseases, Alcañiz Hospital, Spain
Author contributions: Saro C and Sicilia B contributed equally to this work.
Correspondence to: Beatriz Sicilia Aladrén, Service of Digestive Diseases, Alcañiz Hospital, Dr. Repolles 2, 44600 Alcañiz, Teruel, Spain. firstname.lastname@example.org
Telephone: +34-97-8830100 Fax: +34-97-8830977
Received: July 30, 2008 Revised: August 6, 2008
Accepted: August 13, 2008
Published online: September 28, 2008
Inflammatory bowel diseases (IBD) are a heterogeneous group of diseases, not always easy to diagnose, even more difficult to classify, and diagnostic criteria are not always uniform. Well done population-based studies are not abundant, and so comparisons among different geographical areas or populations are not always very reliable. In this article, we have reviewed epidemiological studies available on the world’s population while making a critical review of published data.
© 2008 The WJG Press. All rights reserved.
Key words: Inflammatory bowel diseases; Epidemio-logical; Incidence; Diagnostic criteria
Saro C, Sicilia B. Inflammatory bowel diseases: A disease (s) of modern times? Is incidence still increasing? World J Gastroenterol 2008; 14(36): 5491-5498 Available from: URL: http://www.wjgnet.com/1007-9327/14/5491.asp DOI: http://dx.doi.org/10.3748/wjg.14.5491
There is no doubt about the key role of epidemiology in modern medicine. The burden of inflammatory bowel diseases (IBDs) is changing so quickly, and shows such geographical heterogeneity, that the challenge for epidemiologists is a formidable one. The main goal of this review is to furnish a panorama of these studies all over the world.
First, we have to underline some methodological difficulties. IBDs are a heterogeneous group of diseases, not always easy to diagnose, even more difficult to classify, and diagnostic criteria are not always uniform. And we can not forget that in many countries IBD were rare only 30 years ago. In these stages, hospital based studies are rather common, but of course with many bias. Well done population-based studies are not abundant, and so comparisons among different geographical areas or populations are not always very reliable. The heterogeneity of genotypes and phenotypes has been confirmed in the most recent reports. So, sound studies should be based on clear definitions and internationally accepted classification. Otherwise, some common misconceptions will be perpetuated.
For instance, it is common to find in the introduction of epidemiological reports these type of sentences: “One of the few aspects of the epidemiology of inflammatory bowel disease that seems indisputable is the emergence of both ulcerative colitis and Crohn’s disease in the economically developed nations of Western Europe and North America during the past century” or “It has been suggested that the incidence of inflammatory bowel disease (IBD), which includes Ulcerative colitis and Crohn’s disease, is three or more times higher in Northern than in Southern Europe”. It is the widespread idea that incidence of this group of diseases is low in Africa and Asia, as opposed to the more developed countries, particularly in Northern Europe and Central and North-America. However, other authors are critical with the geographical difference theory and try to clarify the concept: “The incidence figures for Ulcerative colitis and Crohn’s disease have been difficult to interpret, and geographical variations may be due to differences in classification criteria and study design.”
We can see in Figure 1, how epidemiological studies published so far with high quality in methodology (clear definitions, prospective, population-based), are mostly grouped in the same areas[2,4-45] while in areas considered low incidence, coinciding with areas of low socio-economic level, there are no relevant studies. In most undeveloped countries there are few epidemiological studies and the few published until now are limited to very specific areas for a centralized hospital and often retrospectively. The authors of these reports emphasize the probable bias of their results.
In Asia, there is only 1 prospective study in Hong Kong and 4 retrospective studies in Japan, Singapore and Korea[46,49]. Just one study in India and another one in the Arabian Peninsula, in Oman. Studies of Israel are included in Europe. In Africa, data arrive from Cape Town. Recently, a study conducted in New Zealand describes incidence rates similar to those described in “developed” countries or “Northern Europe”.
In the United States, where the health system is not ideal for conducting population studies because 45 million inhabitants are not covered by a health care system, the available studies, though retrospective, are based on the implementation of a “population-based data base of inflammatory bowel disease” which allows the identification of these diseases with a high sensitivity and specificity with the advantage of results over extensive periods of time[7-9]. In Canada it is been used the same methodology for collecting data[4-6].
After all, the general data are not very consistent, so it is difficult to make comparisons. In this article, we have reviewed epidemiological studies available on the world's population while making a critical review of published data.
INCIDENCE RATES IN DIFFERENT EPIDEMIOLOGICAL STUDIES
We show in Table 1 a summary of retrospective studies published until now[4-9,46-92] and the different rates of incidence: as you can see, many of the them are hospital-based[47,48,54,64,77,88,90], not surprisingly showing a worse clinical course with increased morbidity. Population-based studies demonstrate that at least 50% of patients do not require hospital admission, so hospital-based studies are clearly biased showing only the most severe group of patients. We would like to note also that incidence rates are highly variable even in the same geographical areas (for example in UK, incidence varies from 7.1 to 15 for UC)[52,53], a fact explained by methodological heterogeneity.
Prospective and population-based studies
The results of prospective studies (Figure 1) show much more homogeneity. However, there are high incidence areas such as Iceland and Puerto Rico and very low incidence areas such as China and Oman. The other studies do show intermediate rates and, in general the more recent the study the higher the incidence rates[12,20,27]. In most prospective studies, the incidence rates are higher for UC than for CD; only in the Croatian study this ratio is reversed, as is found also in pediatric studies. In Canadian reports incidence rate of UC and CD tend to equalize[4-6], reflecting the high incidence of CD in this country.
In Europe we have multiple population-based and prospective studies, allowing us to comparing different areas (Figures 1, 2 and 3)[2,11-40]. In a multicenter, international, and well designed study led by Shivananda from 1991 to 1993 and covering several areas of Europe comparing the incidence rates of inflammatory bowel disease (IBD) between North and South, the authors did confirm higher incidence rates for Northern (UC = 11.4 and CD = 6.3) than for Southern Europe (UC = 8 and CD = 3.6); however, when you take off extreme data studies (Iceland, Oslo, Lisbon and Ioannina), this difference loses its significance: for Northern Europe (UC = 9.5 and CD = 5.83) vs (UC = 8.79 and CD = 3.84) in Southern Europe. It is worth to remember that in 1991 the socioeconomic status varied greatly in Europe, with Northern countries considerably more wealthy, a gap that is considerably less profound in 2008. With these results, we would like to highlight data from different areas: Exceeding 10 UC patients/100 000 habitants/year: Iceland, Norway[15-17], Copenhagen, Heraklion (Greece) and more recent Spanish studies[27,28]; Between 5 and 10 UC patients/100 000 habitants/year: Leicester (UK), Maastricht, France, Italy, and most Spanish studies[23-25]; Below 5 UC patients/100 000 habitants/year: Croatia, North of France[18,19], Brussels, Germany and Estonia.
Spain is one of the European countries with more prospective and population-based published studies[22-31] (Figure 3). The results are fairly uniform in the studies made at the same time periods, with high incidence areas in the latest published studies as Navarra and Asturias. The results of Spanish studies are not different from those presented throughout Europe (data varying from 5 to 10 cases of UC/100 000 habitants/year and from 3.5 to 6.5 cases of CD/100 000 habitants per year). When comparing the results of the European study, data from Spanish studies are similar: North Europe (UC-CD = 9.5-5.83/100 000 habitants per year) versus (UC-CD = 8.79-3.84/100 000 habitants per year) in southern Europe versus (UC-CD = 7-9.3/4.8-6.08/100 000 habitants per year) in Spain.
VARIATIONS IN INCIDENCE OVER TIME
The general observations in northern Europe and America show that incidence of UC increased substantially in the early and middle third of 1900’s, without changes afterwards, while the incidence of CD has been rising since the mid-1900s. In Western world, it has been a clear increase in incidence in both CD and UC during the sixties and seventies after reaching a plateau between 7 and 12 new cases/100 000 habitants per year, respectively. Nowadays, rates tend to stabilize in areas of high incidence as in northern Europe and America, while in areas with low incidence as southern Europe, Asia and developing countries these incidence dada keep raising.
However, the truth is that we do have little reliable data to establish these comparisons. Few studies are repeated in the same areas and with the same diagnosed criteria or at different consecutive periods or long-term monitoring. In many cases, rates come indirectly from studies with records of hospital admissions and mortality studies. Moreover no less than 12% of patients diagnosed of UC have to be reclassified, as it has been described in some studies. In Figures 3 and 4 we show the studies in the same areas at different periods of time describing differences in incidence rates over time.
In Canada and the United States, and although we have already commented that the methodology is retrospective, data collection of incident cases is comprehensive and based on a database created specifically to collect all incident cases of inflammatory bowel disease; the advantage of these studies is to be able to observe how incidence of these diseases varies over time because data are collected using the same methodology and results are easily comparable. The American Group has published 3 studies[7-9] analyzing the incidence of UC and CD between 1940 and 2000, describing a progressive increase since 1940 in both diseases, afterwards their data remain stable about 30 years, and later on, incidence starts increasing again mainly with CD (increase of 31%) since 1991 remaining UC incidence stable and even declining (7%). The Canadian group has also published 3 studies[4-6] showing the higher incidence of CD never published and described since 1987, remaining stable since then until now; the incidence rates of UC are also high, but similar to other European countries (Iceland, Denmark) and also remains stable.
Analyzing the evolution of incidence rates in European countries we can see that in most of them both rates of UC and CD have been increasing over the years. In relation to UC, we see how the population studies conducted in France[18-20], Greece[34-36] and Netherlands[32,33] show a gradual increase over time; in Norway remains stable and even “declining” but with very high levels (14.8-13.6/100 000 inhabitants per year). In relation to CD, we can see analogous evolution as UC except in France where this trend seems to be the opposite, but with little difference between the studies (4.9-4.05/100 000 habitants per year).
In Spain, we can see how incidence of UC increases gradually with the only exception of one study and also, we can see how clearly CD incidence has increased progressively since 1978 in which the first prospective and population study of CD was conducted in our country with rates of 0.5 patients/100 000 habit per year. The 2 studies conducted more recently in Spain, show really high incidence rates of both UC and CD: Arin et al in Navarra observed an incidence between 2001 and 2003 from UC and EC of 9.57 and 585 patients/100 000 habit per year respectively; the Asturian study (Figure 5), with a long-term follow-up (historical cohort from 1954 until December 2006) noted how since 1954 incident cases of IBD have been gradually increasing, with two points of inflection in the 80’s and in 1991. The first coincides with the introduction of endoscopy in our hospitals as a diagnostic method and the second coincides with the beginning of the prospective study. You can see a clear increase of incidence in the second period of the study, but these results may be biased, since in the first period, the data are retrospective. Finally, in prospective study (1991-2006) there are no significant differences in incidence rates (P = 0.08).
To summarize, we can conclude that: Incidence rates have been increasing in developed countries and finally reaching a plateau in most studies. Data from underdeveloped countries are scarce and of low methodological quality, but most suggest lower incidence rates of IBDs in these areas.
The geographical variability is, in part, the consequence of differences in methods and diagnostic resources. However, when sequential and reliable data are available from the same area, incidence rates do really change.
The rather quick change of incidence does strongly suggest that environmental factors have a clear etiological role in IBDs. The factor (or factors) has something in common with economical development: those diseases seem to raise in parallel with per capita income.
New, methodologically sound studies are needed. We need transversal studies, but longitudinal ones with long-term follow-up will be probably more important to reveal new clues for etiological investigation.
1 Logan RF. Inflammatory bowel disease incidence: up, down or unchanged? Gut 1998; 42: 309-311 PubMed
2 Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M. Incidence of inflammatory
bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative
3 Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, Schulz T, Stray N, Fausa O. Inflammatory bowel disease: re-
evaluation of the diagnosis in a prospective population based study in south eastern Norway. Gut 1997; 40: 328-332
4 Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central
Canadian province: a population-based study. Am J Epidemiol 1999; 149: 916-924 PubMed
5 Blanchard JF, Bernstein CN, Wajda A, Rawsthorne P. Small-area variations and sociodemographic correlates for the
6 Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, Fedorak R, Israel D, Blanchard JF. The
epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006; 101: 1559-
7 Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted
County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998; 114: 1161-1168 PubMed
8 Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted
9 Loftus CG, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ 3rd, Sandborn WJ. Update on the
incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm
10 Appleyard CB, Hernandez G, Rios-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico.
11 Bjyrnsson S, Jyhannsson JH. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide,
epidemiological study. Eur J Gastroenterol Hepatol 2000; 12: 31-38 PubMed
12 Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Bak Andersen I, Wewer V, Norregaard P, Moesgaard F,
Bendtsen F, Munkholm P. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in
Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J
13 Haug K, Schrumpf E, Halvorsen JF, Fluge G, Hamre E, Hamre T, Skjollingstad R. Epidemiology of Crohn's disease in
western Norway. Study group of Inflammatory Bowel Disease in Western Norway. Scand J Gastroenterol 1989; 24:
14 Haug K, Schrumpf E, Barstad S, Fluge G, Halvorsen JF. Epidemiology of ulcerative colitis in western Norway. Scand J
15 Kildebo S, Nordgaard K, Aronsen O, Breckan R, Burhol PG, Jorde R. The incidence of ulcerative colitis in Northern
Norway from 1983 to 1986. The Northern Norwegian Gastroenterology Society. Scand J Gastroenterol 1990; 25: 890-
16 Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Stray N, Sauar J, Schulz T. Incidence of Crohn's disease in
four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-
17 Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Sauar J, Schulz T, Stray N. Incidence of ulcerative colitis and
indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The
Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996;
18 Gower-Rousseau C, Salomez JL, Dupas JL, Marti R, Nuttens MC, Votte A, Lemahieu M, Lemaire B, Colombel JF, Cortot
19 Latour P, Louis E, Belaiche J. Incidence of inflammatory bowel disease in the area of Liege: a 3 years prospective study
(1993-1996). Acta Gastroenterol Belg 1998; 61: 410-413 PubMed
20 Abakar-Mahamat A, Filippi J, Pradier C, Dozol A, Hebuterne X. Incidence of inflammatory bowel disease in Corsica
21 Carr I, Mayberry JF. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and
first- and second- generation South Asians in Leicester (1991-1994). Am J Gastroenterol 1999; 94: 2918-2922 PubMed
22 Ruiz Ochoa V. [Epidemiologic study of Crohn's disease in Galicia from 1976 to 1983] Rev Esp Enferm Apar Dig 1984;
66: 273-279 PubMed
23 Brullet E, Bonfill X, Urrutia G, Ruiz Ochoa V, Cueto M Clofent J. Estudio epidemiológico sobre la incidencia de
Enfermedad Inflamatoria Intestinal en cuatro áreas españolas. Med Clin 1998; 110: 651-656
24 Gomollón F, López J, Sainz R. High incidence of inflammatory bowel disease in Aragón (Spain): a prospective population
based study. Gastroenterology 1995; 108 Suppl: A865
25 Lopez Miguel C, Sicilia B, Sierra E, Lopez Zaborras J, Arribas F, Gomollon F. [Incidence of inflammatory bowel disease
in Aragon: outcome of a prospective population-based study] Gastroenterol Hepatol 1999; 22: 323-328 PubMed
26 Saro Gismera C, Lacort Fernández M, Argüelles Fernández G, Antón Magarzo J, García López R, Navascues CA, Suárez
González A, Díaz Alvarez G, González Bernal A, Palacios Galán A, Altadill Arregui A, Vizoso F. [Incidence and prevalence
of inflammatory bowel disease in Gijon, Asturias, Spain] Gastroenterol Hepatol 2000; 23: 322-327 PubMed
27 Saro Gismera C, de la Coba C, Lacort Fernández M, González Bernal A, Álvarez Álvarez A, Pérez-Pariente JM,
Navascues CA. Changes in incidence of inflammatory bowel disease during the last 15 years: A epidemiological
prospective Population-Based Study from Gijón (Spain) (1992-2006). Gut 2007; 39 (Suppl 1): A129
28 Arin Letamendia A, Borda Celaya F, Burusco Paternain MJ, Prieto Martínez C, Martínez Echeverría A, Elizalde
Apestegui I, Laiglesia Izquierdo M, Macias Mendizábal E, Tamburri Moso P, Sánchez Valverde F. [High incidence rates of
inflammatory bowel disease in Navarra (Spain). Results of a prospective, population-based study] Gastroenterol Hepatol
29 Garrido A, Martinez MJ, Ortega JA, Lobato A, Rodriguez MJ, Guerrero FJ. Epidemiology of chronic inflammatory bowel
disease in the Northern area of Huelva. Rev Esp Enferm Dig 2004; 96: 687-691; 691-694 PubMed
30 Rodrigo L, Riestra S, Nino P, Cadahia V, Tojo R, Fuentes D, Moreno M, Gonzrlez Ballina E, Fernandez E. A population-
based study on the incidence of inflammatory bowel disease in Oviedo (Northern Spain). Rev Esp Enferm Dig 2004; 96:
31 Rivera Irigoín R, de Sola Earle C, Ubiña Aznar E, Perea-Milla E, Fernández Pérez F, Navarro Jarabo JM, García
Fernández G. [Incidence and clinico-epidemiological aspects of ulcerative colitis in the area of the Hospital Costa del Sol]
32 Van Gossum A, Adler M, De Reuck M, Devis G, Fiasse R, Vanheurverzwijn R, Willocx R. Epidemiology of inflammatory
bowel disease in Brussels' area (1992-1993). Acta Gastroenterol Belg 1996; 59: 7-9 PubMed
33 Russel MG, Dorant E, Volovics A, Brummer RJ, Pop P, Muris JW, Bos LP, Limonard CB, Stockbrugger RW. High incidence
of inflammatory bowel disease in The Netherlands: results of a prospective study. The South Limburg IBD Study Group.
34 Manousos ON, Giannadaki E, Mouzas IA, Tzardi M, Koutroubakis I, Skordilis P, Vassilakis S, Kouroumalis E, Vlachonikolis
IG. Ulcerative colitis is as common in Crete as in northern Europe: a 5-year prospective study. Eur J Gastroenterol
Hepatol 1996; 8: 893-898 PubMed
35 Manousos ON, Koutroubakis I, Potamianos S, Roussomoustakaki M, Gourtsoyiannis N, Vlachonikolis IG. A prospective
epidemiologic study of Crohn's disease in Heraklion, Crete. Incidence over a 5-year period. Scand J Gastroenterol 1996;
36 Ladas SD, Mallas E, Giorgiotis K, Karamanolis G, Trigonis D, Markadas A, Sipsa V, Raptis SA. Incidence of ulcerative
colitis in Central Greece: a prospective study. World J Gastroenterol 2005; 11: 1785-1787 PubMed
37 Timmer A, Goebell H. Incidence of ulcerative colitis, 1980-1995--a prospective study in an urban population in Germany.
Z Gastroenterol 1999; 37: 1079-1084 PubMed
38 Ranzi T, Bodini P, Zambelli A, Politi P, Lupinacci G, Campanini MC, Dal Lago AL, Lisciandrano D, Bianchi PA.
Epidemiological aspects of inflammatory bowel disease in a north Italian population: a 4-year prospective study. Eur J
Gastroenterol Hepatol 1996; 8: 657-661 PubMed
39 Sincic BM, Vucelic B, Persic M, Brncic N, Erzen DJ, Radakovic B, Mićović V, Stimac D. Incidence of inflammatory bowel
disease in Primorsko-goranska County, Croatia, 2000-2004: A prospective population-based study. Scand J Gastroenterol
40 Salupere R. Inflammatory bowel disease in Estonia: a prospective epidemiologic study 1993-1998. World J
Gastroenterol 2001; 7: 387-388 PubMed
41 Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm
42 Sood A, Midha V, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut
43 Radhakrishnan S, Zubaidi G, Daniel M, Sachdev GK, Mohan AN. Ulcerative colitis in Oman. A prospective study of the
incidence and disease pattern from 1987 to 1994. Digestion 1997; 58: 266-270 PubMed
44 Wright JP, Froggatt J, O'Keefe EA, Ackerman S, Watermeyer S, Louw J, Adams G, Girdwood AH, Burns DG, Marks IN.
The epidemiology of inflammatory bowel disease in Cape Town 1980-1984. S Afr Med J 1986; 70: 10-15 PubMed
45 Gearry RB, Richardson A, Frampton CM, Collett JA, Burt MJ, Chapman BA, Barclay ML. High incidence of Crohn's disease
46 Yang SK, Yun S, Kim JH, Park JY, Kim HY, Kim YH, Chang DK, Kim JS, Song IS, Park JB, Park ER, Kim KJ, Moon G, Yang
SH. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID
47 Morita N, Toki S, Hirohashi T, Minoda T, Ogawa K, Kono S, Tamakoshi A, Ohno Y, Sawada T, Muto T. Incidence and
prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J
48 Tan CC, Kang JY, Guan R, Yap I, Tay HH. Inflammatory bowel disease: an uncommon problem in Singapore. J
49 Yang SK, Hong WS, Min YI, Kim HY, Yoo JY, Rhee PL, Rhee JC, Chang DK, Song IS, Jung SA, Park EB, Yoo HM, Lee DK,
Kim YK. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J
50 Gilat T, Ribak J, Benaroya Y, Zemishlany Z, Weissman I. Ulcerative colitis in the Jewish population of Tel-Aviv Jafo. I.
Epidemiology. Gastroenterology 1974; 66: 335-342 PubMed
51 Sinclair TS, Brunt PW, Mowat NA. Nonspecific proctocolitis in northeastern Scotland: a community study.
Gastroenterology 1983; 85: 1-11 PubMed
52 Morris T, Rhodes J. Incidence of ulcerative colitis in the Cardiff region 1968-1977. Gut 1984; 25: 846-848 PubMed
53 Devlin HB, Datta D, Dellipiani AW. The incidence and prevalence of inflammatory bowel disease in North Tees Health
54 Binder V, Both H, Hansen PK, Hendriksen C, Kreiner S, Torp-Pedersen K. Incidence and prevalence of ulcerative colitis
and Crohn's disease in the County of Copenhagen, 1962 to 1978. Gastroenterology 1982; 83: 563-568 PubMed
55 Jacobsohn WZ, Levine Y. Incidence and prevalence of ulcerative colitis in the Jewish population of Jerusalem. Isr J Med
Sci 1986; 22: 559-563 PubMed
56 Stonnington CM, Phillips SF, Melton LJ 3rd, Zinsmeister AR. Chronic ulcerative colitis: incidence and prevalence in a
57 Nyhlin H, Danielsson A. Incidence of Crohn's disease in a defined population in northern Sweden, 1974-1981. Scand J
58 Stewénius J, Adnerhill I, Ekelund G, Florén CH, Fork FT, Janzon L, Lindström C, Mars I, Nyman M, Rosengren JE.
Ulcerative colitis and indeterminate colitis in the city of Malmo, Sweden. A 25-year incidence study. Scand J
59 Grossman A, Fireman Z, Lilos P, Novis B, Rozen P, Gilat T. Epidemiology of ulcerative colitis in the Jewish population of
central Israel 1970-1980. Hepatogastroenterology 1989; 36: 193-197 PubMed
60 Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based
study in Sweden. Gastroenterology 1991; 100: 350-358 PubMed
61 Shivananda S, Pena AS, Mayberry JF, Ruitenberg EJ, Hoedemaeker PJ. Epidemiology of proctocolitis in the region of
Leiden, The Netherlands. A population study from 1979 to 1983. Scand J Gastroenterol 1987; 22: 993-1002 PubMed
62 Odes HS, Fraser D, Krawiec J. Ulcerative colitis in the Jewish population of southern Israel 1961-1985: epidemiological
63 Odes HS, Fraser D, Krawiec J. Incidence of idiopathic ulcerative colitis in Jewish population subgroups in the Beer Sheva
region of Israel. Am J Gastroenterol 1987; 82: 854-858 PubMed
64 Stowe SP, Redmond SR, Stormont JM, Shah AN, Chessin LN, Segal HL, Chey WY. An epidemiologic study of
inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology 1990; 98: 104-110 PubMed
65 Niv Y, Torten D, Tamir A, Epstein L. Incidence and prevalence of ulcerative colitis in the upper Galilee, Northern Israel,
1967-1986. Am J Gastroenterol 1990; 85: 1580-1583 PubMed
66 Lindberg E, Jarnerot G. The incidence of Crohn's disease is not decreasing in Sweden. Scand J Gastroenterol 1991; 26:
67 Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen
68 Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of
69 Lapidus A, Bernell O, Hellers G, Persson PG, Lofberg R. Incidence of Crohn's disease in Stockholm County 1955-1989.
Gut 1997; 41: 480-486 PubMed
70 Bjornsson S, Johannsson JH, Oddsson E. Inflammatory bowel disease in Iceland, 1980-89. A retrospective nationwide
71 Thomas GA, Millar-Jones D, Rhodes J, Roberts GM, Williams GT, Mayberry JF. Incidence of Crohn's disease in Cardiff
over 60 years: 1986-1990 an update. Eur J Gastroenterol Hepatol 1995; 7: 401-405 PubMed
72 Tsianos EV, Masalas CN, Merkouropoulos M, Dalekos GN, Logan RF. Incidence of inflammatory bowel disease in north
west Greece: rarity of Crohn's disease in an area where ulcerative colitis is common. Gut 1994; 35: 369-372 PubMed
73 Odes HS, Locker C, Neumann L, Zirkin HJ, Weizman Z, Sperber AD, Fraser GM, Krugliak P, Gaspar N, Eidelman L.
Epidemiology of Crohn's disease in southern Israel. Am J Gastroenterol 1994; 89: 1859-1862 PubMed
74 Fonager K, Sorensen HT, Olsen J. Change in incidence of Crohn's disease and ulcerative colitis in Denmark. A study
75 Tragnone A, Corrao G, Miglio F, Caprilli R, Lanfranchi GA. Incidence of inflammatory bowel disease in Italy: a
nationwide population-based study. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Int J Epidemiol 1996; 25:
76 Trallori G, Palli D, Saieva C, Bardazzi G, Bonanomi AG, d'Albasio G, Galli M, Vannozzi G, Milla M, Tarantino O, Renai F,
Messori A, Amorosi A, Pacini F, Morettini A. A population-based study of inflammatory bowel disease in Florence over 15
77 Linares de la Cal JA, Canton C, Hermida C, Perez-Miranda M, Mate-Jimenez J. Estimated incidence of inflammatory
bowel disease in Argentina and Panama (1987-1993). Rev Esp Enferm Dig 1999; 91: 277-286 PubMed
78 Shapira M, Tamir A. Ulcerative colitis in the Kinneret sub district, Israel 1965-1994: incidence and prevalence in
79 Yapp TR, Stenson R, Thomas GA, Lawrie BW, Williams GT, Hawthorne AB. Crohn's disease incidence in Cardiff from
1930: an update for 1991-1995. Eur J Gastroenterol Hepatol 2000; 12: 907-911 PubMed
80 Rubin GP, Hungin AP, Kelly PJ, Ling J. Inflammatory bowel disease: epidemiology and management in an English general
81 Niv Y, Abuksis G, Fraser GM. Epidemiology of Crohn's disease in Israel: a survey of Israeli kibbutz settlements. Am J
82 García Rodríguez LA, Gonzalez-Perez A, Johansson S, Wallander MA. Risk factors for inflammatory bowel disease in
83 Tsianos EV, Katsanos KH, Christodoulou D, Dimoliatis I, Kogevinas A, Logan RF. Continuing low incidence of Crohn's
84 Molinie F, Gower-Rousseau C, Yzet T, Merle V, Grandbastien B, Marti R, Lerebours E, Dupas JL, Colombel JF, Salomez
JL, Cortot A. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999).
85 Lakatos L, Mester G, Erdelyi Z, Balogh M, Szipocs I, Kamaras G, Lakatos PL. Striking elevation in incidence and
prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World J Gastroenterol
2004; 10: 404-409 PubMed
86 Lapidus A. Crohn's disease in Stockholm County during 1990-2001: an epidemiological update. World J Gastroenterol
2006; 12: 75-81 PubMed
87 Tsironi E, Feakins RM, Probert CS, Rampton DS, Phil D. Incidence of inflammatory bowel disease is rising and abdominal
tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am J Gastroenterol 2004; 99: 1749-1755
88 Al-Ghamdi AS, Al-Mofleh IA, Al-Rashed RS, Al-Amri SM, Aljebreen AM, Isnani AC, El-Badawi R. Epidemiology and
outcome of Crohn's disease in a teaching hospital in Riyadh. World J Gastroenterol 2004; 10: 1341-1344 PubMed
89 Jacobsen BA, Fallingborg J, Rasmussen HH, Nielsen KR, Drewes AM, Puho E, Nielsen GL, Sorensen HT. Increase in
incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002.
90 Gheorghe C, Pascu O, Gheorghe L, Iacob R, Dumitru E, Tantau M, Vadan R, Goldis A, Balan G, Iacob S, Dobru D, Saftoiu
A. Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicentre
91 Nerich V, Monnet E, Etienne A, Louafi S, Ramee C, Rican S, Weill A, Vallier N, Vanbockstael V, Auleley GR, Allemand H,
Carbonnel F. Geographical variations of inflammatory bowel disease in France: a study based on national health
92 Cachia E, Calleja N, Aakeroy R, Degaetano J, Vassallo M. Incidence of inflammatory bowel disease in Malta between
93 Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental
94 Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347: 911-
S- Editor Xiao LL E- Editor Yin DH